Targeted Genetics Corporation
News and overview for Targeted Genetics Corporation
Targeted Genetics Corporation Reports Third Quarter 2009 Financial Results [Press Release]
Business Wire | 5 days 21 hours 23 minutes ago
Targeted Genetics Corporation (NASDAQ: TGEN) today announced its financial results for the third quarter ended September 30, 2009.
Research and Markets: Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities [Press Release]
Business Wire | 20 days 3 hours 38 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/8f18b5/delivering_rnaiba) has announced the addition of the "Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities" report to their offering.
Research and Markets: Cancer Therapies - Global Market Opportunities [Press Release]
Business Wire | 3 days 4 hours 59 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/4b82d8/cancer_therapies) has announced the addition of the "Cancer Therapies - Global Market Opportunities" report to their offering.
Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors [Press Release]
PRNewswire | 48 days 6 hours 33 minutes ago
SEATTLE, Oct. 5 /PRNewswire-FirstCall/ - Oncothyreon Inc.
Reportlinker Adds World Cancer Therapies Market Report [Press Release]
PRNewswire | 73 days 5 hours 36 minutes ago
...analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy...Myers Squibb Company, Celgene Corporation, Cell Therapeutics, Inc...Aventis, Schering Plough Corporation, Seattle Genetics, Inc., Takeda Pharmaceutical...
Third quarter financial results announced by SemBioSys Genetics
News-Medical.Net | 9 days 5 hours 14 minutes ago
SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, today announced its third quarter 2009 financial and operational results.
First Advantage Announces Investment in EnticeLabs [Press Release]
PRNewswire | 53 days 4 hours 36 minutes ago
...First Advantage Corporation today announced...product, uses highly targeted ads and advanced...intelligence and genetics provides dramatically...industry, using targeted ads and advanced...First Advantage Corporation provides innovative...First American Corporation , a FORTUNE 500...
Canaccord Adams hosts 29th Annual Global Growth Conference: August 11-13, 2009: Boston [Press Release]
PRNewswire | 107 days 22 hours 37 minutes ago
- Investor conference features 240 small and mid-cap companies in six sectors - - 50+ next-generation companies will present at the Private Company Showcase - - Knowledge sessions will feature key topics in targeted coverage areas -
8 Results
Sign up for AABB SmartBrief
Company Overview
| Company: | Targeted Genetics Corporation |
|---|---|
| Industry: | Biopharmaceuticals & Biotherapeutics |
| Website: | http://www.targetedgenetics.com |
Targeted Genetics is putting the bull's-eye on disease. The drug developer is working in the promising (though as yet unproven) field of gene therapies, drugs that deliver particular DNA sequences into targeted cells to encourage (or sometimes inhibit) the production of proteins associated with disease. The company's drug candidates -- targeting conditions such as retinal dystrophies, lateral sclerosis, HIV/AIDS, heart failure, and Huntington's disease -- employ proprietary technology using bio-engineered viral cells (called vectors) to deliver the genes. The company is working on its own to develop therapies for certain candidates and with development partners on some other programs.
Key Numbers
| Sales in U.S. Dollars (mil.) | 8.7 (2008) |
|---|---|
| One-year % Growth in Sales | -15.6 (2008) |
| Net Income in U.S. Dollars (mil.) | -20.7 (2008) |
| One-year % Growth in Net Income | 0.0 (2008) |
| Number of Employees | 58 (2008) |
| One-year % Growth in Number of Employees | -20.5 (2008) |
| Fiscal Year-End | December |